This IMO falls right in line with what all Joe has
Post# of 85484
Through Patent-Pending Transdermal Patch to Treat
COVID-19. The patent-pending transdermal patch, developed in partnership with UNIVEC, seeks to relieve pain and inflammation and boost the immune system.
OK A LITTLE FARTHER WE GO NOTE PATCHES MORE THAN ONE WHEN DALTON GIVES US THE PR THAT WILL BRING NEW BEGININS IT WILL BE HUGE AND THERE IS A GREAT POSSIBLITY ITS THIS WEEK:
Ok Joe told me his self that all of UNIVEC Products are going directly to Big Pharmacies and Large Distributors. Plus all products were developed with the help of the University of Maryland BioPark WHICH DALTON IS ON THE BOARD... I ASK STRAIGHT FOWARD IF DALTON WAS LETTING HIM TELL ME ANYTHING NEW, HIS ANSWER WAS NOT TODAY BUT MORE LIKELY NEXT WEEK. THE MORE LIKELY NEXT WEEK IS A DIRECT QUOTE WHICH IS THIS WEEK THIS WAS LAST FRIDAY THE 28TH
TOODLES